CML Neurology

» Advanced search

Paper of the Month - June, 2010

• View Archive »

  • The mechanism of action of retigabine (ezogabine), a first-in-class K(+) channel opener for the treatment of epilepsy. - March, 2012
    Glucose transporter 1 deficiency as a treatable cause of myoclonic astatic epilepsy. - February, 2012
    Training-related brain plasticity in subjects at risk of developing Alzheimer's disease. - January, 2012
    Wine drinking and essential tremor: a possible protective role. - December, 2011
    Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam. - November, 2011
    Validation of the ABCD²-I score to predict stroke risk after transient ischemic attack. - October, 2011
    A 5-year prospective assessment of advanced Parkinson disease patients treated with subcutaneous apomorphine infusion or deep brain stimulation. - September, 2011
    Long-term consolidation of declarative memory: insight from temporal lobe epilepsy. - August, 2011
    Exome sequencing of ion channel genes reveals complex profiles confounding personal risk assessment in epilepsy. - July, 2011
    Accuracy of clinical diagnosis in tremulous parkinsonian patients: a blinded video study. - June, 2011
    Implementation and outcome of thrombolysis with alteplase 3–4.5 h after an acute stroke: an updated analysis from SITS-ISTR. - May, 2011
    Early carotid endarterectomy following thrombolysis in the hyperacute treatment of stroke. - April, 2011
    Early carotid surgery in patients after acute ischemic stroke: is it safe? A retrospective analysis in a single center between early and delayed/deferred carotid surgery on 285 patients. - March, 2011
    A short olfactory test based on the identification of three odors. - February, 2011
    Management of thrombolysis-associated symptomatic intracerebral hemorrhage. - January, 2011
    Agreement regarding diagnosis of transient ischemic attack fairly low among stroke-trained neurologists. - December, 2010
    Levodopa response in early Parkinson’s disease. - November, 2010
    Myopathy causing camptocormia in idiopathic Parkinson’s disease: a multidisciplinary approach. - October, 2010
    Increased expression of cholesterol transporter ABCA1 is highly correlated with severity of dementia in AD hippocampus. - September, 2010
    The role of DAT-SPECT in movement disorders - August, 2010
    Cognitive deficits in chronic heart failure. - July, 2010
    Embolic stroke associated with injection of buprenorphine tablets. - June, 2010
    Angelman syndrome: current understanding and research prospects. - May, 2010
    The present efficacy of multiple sclerosis therapeutics: is the new 66% just the old 33%? - April, 2010
    Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the Phase 3 BENEFIT trial. - March, 2010
    Self administered cognitive screening test (TYM) for detection of Alzheimers disease: cross sectional study. - February, 2010
    Can the ABCD2 risk score predict positive diagnostic testing for emergency department patients admitted for transient ischemic attack? - January, 2010
    Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson’s disease. - 2009
    Treatment with galantamine and time to nursing home placement in Alzheimer’s disease patients with and without cerebrovascular disease. - 2009
    Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. - 2009
    Controlling Hypertension and Hypotension Immediately Post-Stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. - 2009
    Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques. - 2009
    Parkinson’s disease dementia: definitions, guidelines and research perspectives in diagnosis. - 2009
    Incidence and remaining lifetime risk of Parkinson’s disease in advanced age. - 2009
    Knowing – or not knowing – when to stop: cognitive decline in ageing doctors. - 2009
    Controlling Hypertension and Hypotension Immediately Post-Stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. - 2009
    CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer’s disease. - 2009
    High-frequency rTMS over the supplementary motor area for the treatment of Parkinson’s disease. - 2009
    Levodopa improves procedural motor learning in chronic stroke patients. - 2009